Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1947 3
1950 10
1953 2
1955 1
1956 2
1957 1
1960 1
1961 2
1967 1
1968 1
1969 1
1970 3
1972 3
1973 7
1974 2
1975 10
1976 8
1977 9
1978 6
1979 6
1980 5
1981 8
1982 6
1983 5
1984 11
1985 11
1986 8
1987 16
1988 12
1989 15
1990 13
1991 15
1992 18
1993 9
1994 16
1995 15
1996 12
1997 13
1998 16
1999 21
2000 11
2001 33
2002 20
2003 17
2004 19
2005 23
2006 26
2007 19
2008 26
2009 29
2010 38
2011 26
2012 17
2013 21
2014 27
2015 26
2016 20
2017 21
2018 28
2019 19
2020 18
2021 21
2022 10
2023 20
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

809 results

Results by year

Filters applied: . Clear all
Page 1
Ki-67: more than a proliferation marker.
Sun X, Kaufman PD. Sun X, et al. Among authors: kaufman pd. Chromosoma. 2018 Jun;127(2):175-186. doi: 10.1007/s00412-018-0659-8. Epub 2018 Jan 10. Chromosoma. 2018. PMID: 29322240 Free PMC article. Review.
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.
Sledge GW Jr, Toi M, Neven P, Sohn J, Inoue K, Pivot X, Burdaeva O, Okera M, Masuda N, Kaufman PA, Koh H, Grischke EM, Frenzel M, Lin Y, Barriga S, Smith IC, Bourayou N, Llombart-Cussac A. Sledge GW Jr, et al. Among authors: kaufman pa. J Clin Oncol. 2017 Sep 1;35(25):2875-2884. doi: 10.1200/JCO.2017.73.7585. Epub 2017 Jun 3. J Clin Oncol. 2017. PMID: 28580882 Clinical Trial.
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial.
Sledge GW Jr, Toi M, Neven P, Sohn J, Inoue K, Pivot X, Burdaeva O, Okera M, Masuda N, Kaufman PA, Koh H, Grischke EM, Conte P, Lu Y, Barriga S, Hurt K, Frenzel M, Johnston S, Llombart-Cussac A. Sledge GW Jr, et al. Among authors: kaufman pa. JAMA Oncol. 2020 Jan 1;6(1):116-124. doi: 10.1001/jamaoncol.2019.4782. JAMA Oncol. 2020. PMID: 31563959 Free PMC article. Clinical Trial.
Iovs 2008-2012.
Kaufman PL. Kaufman PL. Invest Ophthalmol Vis Sci. 2012 Dec 10;53(13):8238-9. doi: 10.1167/iovs.12-11331. Invest Ophthalmol Vis Sci. 2012. PMID: 23230304 No abstract available.
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, Bachelot T, Wright GS, Saura C, Escrivá-de-Romaní S, De Laurentiis M, Schwartz GN, Pluard TJ, Ricci F, Gwin WR 3rd, Levy C, Brown-Glaberman U, Ferrero JM, de Boer M, Kim SB, Petráková K, Yardley DA, Freedman O, Jakobsen EH, Gal-Yam EN, Yerushalmi R, Fasching PA, Kaufman PA, Ashley EJ, Perez-Olle R, Hong S, Rosales MK, Gradishar WJ; SOPHIA Study Group. Rugo HS, et al. Among authors: kaufman pa. J Clin Oncol. 2023 Jan 10;41(2):198-205. doi: 10.1200/JCO.21.02937. Epub 2022 Nov 4. J Clin Oncol. 2023. PMID: 36332179 Free PMC article. Clinical Trial.
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N. Romond EH, et al. Among authors: kaufman pa. N Engl J Med. 2005 Oct 20;353(16):1673-84. doi: 10.1056/NEJMoa052122. N Engl J Med. 2005. PMID: 16236738 Free article. Clinical Trial.
The prostaglandin wars.
Kaufman PL. Kaufman PL. Am J Ophthalmol. 2003 Oct;136(4):727-8. doi: 10.1016/s0002-9394(03)00658-5. Am J Ophthalmol. 2003. PMID: 14516814 No abstract available.
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane.
Kaufman PA, Awada A, Twelves C, Yelle L, Perez EA, Velikova G, Olivo MS, He Y, Dutcus CE, Cortes J. Kaufman PA, et al. J Clin Oncol. 2015 Feb 20;33(6):594-601. doi: 10.1200/JCO.2013.52.4892. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605862 Free PMC article. Clinical Trial.
Glaucoma Drugs in the Pipeline.
Kaufman PL, Mohr ME, Riccomini SP, Rasmussen CA. Kaufman PL, et al. Asia Pac J Ophthalmol (Phila). 2018 Sep-Oct;7(5):345-351. doi: 10.22608/APO.2018298. Epub 2018 Sep 17. Asia Pac J Ophthalmol (Phila). 2018. PMID: 30221499 Free article. Review.
809 results